Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy

被引:15
|
作者
Rieken, M. [1 ,2 ]
Kluth, L. A. [1 ,3 ]
Xylinas, E. [1 ,4 ]
Seitz, C. [5 ]
Fajkovic, H. [5 ]
Karakiewicz, P. I. [6 ]
Lotan, Y. [7 ]
Briganti, A. [8 ]
Loidl, W. [9 ]
Faison, T. [1 ]
Crivelli, J. J. [1 ]
Scherr, D. S. [1 ]
Bachmann, A. [2 ]
Tewari, A. K. [1 ]
Kautzky-Willer, A. [10 ]
Pummer, K. [11 ]
Shariat, S. F. [1 ,5 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Urol, New York, NY USA
[2] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland
[3] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[4] Univ Paris 05, Cochin Hosp, AP HP, Dept Urol, Paris, France
[5] Med Univ Vienna, Dept Urol, A-1090 Vienna, Austria
[6] Univ Montreal, Dept Urol, Montreal, PQ, Canada
[7] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[8] Ist Sci San Raffaele, Urol Res Inst, Dept Urol, I-20132 Milan, Italy
[9] Hosp Barmherzige Schwestern Linz, Prostate Canc Ctr, Linz, Austria
[10] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Unit Gender Med, A-1090 Vienna, Austria
[11] Med Univ Graz, Dept Urol, Graz, Austria
基金
瑞士国家科学基金会;
关键词
statins; radical prostatectomy; biochemical recurrence; HOSPITAL SEARCH DATABASE; CANCER RECURRENCE; RADIATION-THERAPY; METAANALYSIS; OUTCOMES; RADIOTHERAPY; CHOLESTEROL; RISK; MEN;
D O I
10.1038/pcan.2013.31
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The impact of statin use on biochemical recurrence (BCR) in patients treated with radical prostatectomy (RP) remains controversial. METHODS: We retrospectively evaluated 6842 patients who underwent RP for clinically localized prostate cancer (PC) between 2000 and 2011. Uni- and multivariable cox regression models addressed the association of statin use with BCR. RESULTS: Overall, 2275 (33.3%) patients used statins. Statin users were older and had a higher rate of positive surgical margins than patients not using statins (P-values <= 0.05). Within a median follow-up of 25 months (interquartile range: 8-42 months), 778 (11.4%) patients experienced BCR. Actuarial estimate 5-years BCR-free survival was 82% +/- 1 for patients without statin use and 84 +/- 1% for patients using statins (P = 0.05); statin use was not associated with BCR (hazard ratio: 0.88, 95% confidence interval: 0.76-1.03, P = 0.10) after adjusting for the effects of standard clinicopathologic features. CONCLUSIONS: In PC patients undergoing RP, statin use was not independently associated with lower risk of BCR.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 50 条
  • [1] Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
    M Rieken
    L A Kluth
    E Xylinas
    C Seitz
    H Fajkovic
    P I Karakiewicz
    Y Lotan
    A Briganti
    W Loidl
    T Faison
    J J Crivelli
    D S Scherr
    A Bachmann
    A K Tewari
    A Kautzky-Willer
    K Pummer
    S F Shariat
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 367 - 371
  • [2] Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy
    Prabhu, Nicole
    Kapur, Navina
    Catalona, William
    Leikin, Robin
    Helenowski, Irene
    Jovanovich, Borko
    Gurley, Michael
    Okwuosa, Tochi M.
    Kuzel, Timothy M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 130.e9 - 130.e15
  • [3] THE IMPACT OF PROSTATE VOLUME ON BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY
    Gandaglia, Giorgio
    Briganti, Alberto
    Moschini, Marco
    Suardi, Nazareno
    Gallina, Andrea
    La Croce, Giovanni
    Capitanio, Umberto
    Nini, Alessandro
    Colombo, Renzo
    Montorsi, Francesco
    Scattoni, Vincenzo
    ANTICANCER RESEARCH, 2014, 34 (05) : 2662 - 2663
  • [4] Statin Use after Radical Prostatectomy Reduces Biochemical Recurrence in Men With Prostate Cancer
    Song, Cheryn
    Park, Sejun
    Park, Jinsung
    Shim, Myungsun
    Kim, Aram
    Jeong, In Gab
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    PROSTATE, 2015, 75 (02): : 211 - 217
  • [5] Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading
    Lyon, Timothy D.
    Turner, Robert M., II
    Yabes, Jonathan G.
    Woldemichael, Elen
    Davies, Benjamin J.
    Jacobs, Bruce L.
    Nelson, Joel B.
    UROLOGY, 2016, 97 : 153 - 159
  • [6] IMPACT OF STATIN USE ON BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS TREATED WITH RADIATION THERAPY
    Lavigne, Danny
    Kaulanjan, Kevin
    Hoeh, Benedikt
    Saad, Fred
    Karakiewicz, Pierre I.
    Flammia, Rocco Simone
    Kluth, Luis Alex
    Mandel, Philipp
    Chun, Felix K. H.
    Taussky, Daniel
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S67 - S68
  • [7] IMPACT OF STATIN USE ON PATHOLOGIC FEATURES IN MEN TREATED WITH RADICAL PROSTATECTOMY
    Rioja, Jorge
    Pinochet, Rodrigo
    Savage, Caroline J.
    Guillonneau, Bertrand D.
    Scardino, Peter T.
    Eastham, James A.
    Parra, Raul O.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E51 - E51
  • [8] Machine Learning for the Prediction of Biochemical Recurrence in Patients Treated with Radical Prostatectomy
    Sabbagh, A.
    Trock, B.
    Partin, A. W.
    Wu, J.
    Chen, M. H.
    Tilki, D.
    DAmico, A. V.
    Mohamad, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E484 - E484
  • [9] Impact of Statin Use on Biochemical Failure following Radical Prostatectomy or Radiation Therapy
    Huynh, L.
    Keit, E.
    Carrillo, R.
    Huang, E.
    Ahlering, T.
    Boyle, S.
    Enke, C.
    Baine, M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1181 - S1182
  • [10] Pathological Characteristics, Biochemical Recurrence and Functional Outcome in Radical Prostatectomy Patients on Statin Therapy
    Kontraros, M.
    Varkarakis, I.
    Ntoumas, K.
    Deliveliotis, C.
    UROLOGIA INTERNATIONALIS, 2013, 90 (03) : 263 - 269